LAS VEGAS, Sept. 24, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB:Â AVAI)Â ("Avant" or the "Company"), a Nevada-based corporation, Art-Islets Pte. Ltd. ("Art-Islets") and Austrianova (SGAustria Pte. Ltd.), both Singapore-based biotechnology companies, today announced the formation of a groundbreaking Joint Venture and License Agreement aimed at revolutionizing a diabetes treatment through innovative stem cell and encapsulation technologies. Continue Reading Avant Technologies This strategic collabor ...